Press Room

First ever combination of robotic and biological vision in humans - 5/4/2016
Scientistshave successfully implanted a prosthesis that restores some central vision inpatients with only limited peripheral vision remaining to them – the first timeartificial and natural vision has ever been integrated in humans. The researchis being presented at the 2016 Annual Meeting of the Association for Researchin Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Ebola may lead to blindness in survivors according to new findings - 5/4/2016
A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

Study finds blueberries may protect against dry eye disease - 5/4/2016
Pterostilbene(PS), a component of blueberries, have been found to protect against dry eyedisease according to a new study. The research is being presented at the 2016Annual Meeting of the Association for Research in Vision and Ophthalmology(ARVO) this week in Seattle, Wash.

Emerging trends and hot topics: Presented Wednesday, May 4 at the ARVO Annual Meeting - 5/4/2016
In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Wednesday, May 4.


Emerging trends and hot topics: Presented Tuesday, May 3 at the ARVO Annual Meeting - 5/3/2016

In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Tuesday, May 3.



Emerging trends and hot topics: Presented Monday, May 2 at the ARVO Annual Meeting - 5/2/2016
In their own words, First Authors at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Monday, May 2.

Media Invitation: Press Conference at ARVO 2016 by Webcast - 5/1/2016
Press conference by webcast whole eye transplant and other eye research advances from the ARVO 2016 Annual Meeting

Emerging trends and hot topics: Presented Sunday, May 1 at the ARVO Annual Meeting - 5/1/2016

In their own words, First Authors at the 2016 Annual Meeting of theAssociation for Research in Vision and Ophthalmology explain their findings.Their abstracts were designated as some of the newest and most innovative research presented on Sunday, May 1.



Former Seahawks quarterback Jim Zorn and Congressman James McDermott, MD (WA 7) - 4/21/2016
More than 75% of all TBI patients experience visual disorders, including double vision, light sensitivity, difficulty reading print and even vision loss.

Can you trust your gut on a crowd’s mood? - 1/13/2016
There is good news for frequent public speakers. New research shows that individuals have the ability to quickly and accurately identify a crowd’s general emotion as focused or distracted, suggesting that we can trust our first impression of a crowd’s mood. 

Scientists find potential target for dry AMD - 11/2/2015

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science (IOVS), the findings indicate that treatments currently used for other conditions could also work for dry AMD.



Can your brain control how it loses control? - 8/13/2015
A new study may have unlocked understanding of a mysterious part of the brain — with implications for neurodegenerative conditions such as Alzheimer’s. The results, published in Translational Vision Science & Technology (TVST), open up new areas of research in the pursuit of neuroprotective therapies.

ARVO Foundation announces new David L. Epstein Award for glaucoma research - 8/2/2015
To honor the memory of a longtime leader in glaucoma treatment and research, the ARVO Foundation for Eye Research will present the Dr. David L. Epstein Award. The new award — a $100,000 prize — was established by the late Dr. Epstein's family and will be presented annually to a senior-level glaucoma researcher at the ARVO Annual Meeting.

Clark begins term as ARVO president - 6/22/2015
John I. Clark, PhD, FARVO, (University of Washington) is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds William F. Mieler, MD, FARVO, (University of Illinois at Chicago), whose one-year term ended in May following the ARVO Annual Meeting.

Researchers find Ebola virus in patient’s eye fluid weeks after it was undetectable in blood - 5/7/2015
Researchers gave the first public presentation at the ARVO 2015 Annual Meeting of a case study in which viable Ebola virus was present in the eye's aqueous humor - the clear fluid in the front of the eye, between the lens and the cornea - 10 weeks after the virus was no longer detectable in the patient's blood.

Implant may eliminate need for eye drops after cataract surgery - 5/7/2015
Researchers have developed a drug-releasing implant that controls pain and inflammation, eliminating the need for eye drops following cataract surgery. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

FDA-approved drug may prevent vision loss - 5/7/2015
An FDA-approved oral medication, 4-phenylbutyrate (PBA), has been found to prevent vision loss in mice with Leber’s congenital amaurosis (LCA). The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Emerging technique gives snapshot of an individual eye cell’s health - 5/7/2015
Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

New treatment may stop progression of eye disease in teens eye cell’s health - 5/7/2015
Doctors have developed a new treatment capable of halting the progression of keratoconus, a progressive eye disease that manifests in teenagers. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Mobile app helps screen for strabismus - 5/6/2015
Researchers have developed a mobile app to quickly and conveniently evaluate people for strabismus, a condition involving misalignment of the eyes. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

12Next
Advertisement
Leica